Afrezza - The Only Inhaled Insulin for Diabetes.
 |
| AFREZZA - The Only Inhaled Insulin For Diabetes. |
Afrezza® is an inhaled human insulin indicated to help improve glycemic control in adults with diabetes mellitus.
Afrezza is a rapid-acting , inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The product consists of a dry formulation of human insulin delivered from a small and portable inhaler.
Administered at the beginning of a meal , Afrezza dissolves rapidly upon inhalation to the lung and delivers insulin quickly to the bloodstream. Peak insulin levels are achieved within 12–15 minutes of administration. Afrezza is available in 4-unit and 8-unit single dose cartridges of insulin powder that can be used , as prescribed by a health care professional , in combination with other diabetes medications to achieve target blood sugar levels. For Afrezza doses exceeding 8 units , patients may use a combination of 4 unit and 8 unit cartridges. Other sizes of cartridges are being considered. The disposable inhaler can be used for up to 15 days , should be kept in a clean , dry place with the mouthpiece cover on and may be wiped with a clean , dry cloth if needed.
LIMITATIONS OF USE
Do not use Afrezza as a substitute for long-acting insulin;
Afrezza must be used in combination with long-acting insulin in patients with type 1 diabetes.
Do not use Afrezza to treat diabetic ketoacidosis. Afrezza is not recommended in patients who smoke or who have recently stopped smoking.
IMPORTANT SAFETY INFORMATION FOR AFREZZA
WARNING: RISK OF ACUTE BRONCHOSPASM IN PATIENTS WITH CHRONIC LUNG DISEASE
- Acute bronchospasm has been observed in patients with asthma and COPD using Afrezza.
- Afrezza is contraindicated in patients with chronic lung disease such as asthma or COPD.
- Before initiating Afrezza , perform a detailed medical history , physical examination , and spirometry (FEV1) to identify potential lung disease in all patients.
Do not use Afrezza if you have problems with your lungs , such as asthma or COPD. Do not use Afrezza during a low blood sugar reaction (hypoglycemia). If you are allergic to any of the ingredients in Afrezza , do not use Afrezza as this may cause a significant and severe allergic reaction.
Resources:-
